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RESEARCH
Engineering of CYP76AH15 can improve 
activity and specificity towards forskolin 
biosynthesis in yeast
Victor Forman1,2, Niels Bjerg‑Jensen2, Jane D. Dyekjær2, Birger Lindberg Møller1,3,4 and Irini Pateraki1,3* 
Abstract 
Background: Forskolin is a high‑value diterpenoid produced exclusively by the Lamiaceae plant Coleus forskohlii. 
Today forskolin is used pharmaceutically for its adenyl‑cyclase activating properties. The limited availability of pure  
forskolin is currently hindering its full utilization, thus a new environmentally friendly, scalable and sustainable strategy 
is needed for forskolin production. Recently, the entire biosynthetic pathway leading to forskolin was elucidated. The 
key steps of the pathway are catalyzed by cytochrome P450 enzymes (CYPs), which have been shown to be the limit‑
ing steps of the pathway. Here we study whether protein engineering of the substrate recognition sites (SRSs) of CYPs 
can improve their efficiency towards forskolin biosynthesis in yeast.
Results: As a proof of concept, we engineered the enzyme responsible for the first putative oxygenation step of the 
forskolin pathway: the conversion of 13R‑manoyl oxide to 11‑oxo‑13R‑manoyl oxide, catalyzed by the CYP76AH15. 
Four CYP76AH15 variants—engineered in the SRS regions—yielded at least a twofold increase of 11‑oxo‑13R‑manoyl 
oxide when expressed in yeast cells grown in microtiter plates. The highest titers (5.6‑fold increase) were observed 
with the variant A99I, mutated in the SRS1 region. Double or triple CYP76AH15 mutant variants resulted in additional 
enzymes with optimized performances. Moreover, in planta CYP76AH15 can synthesize ferruginol from miltiradiene. 
In this work, we showed that the mutants affecting 11‑oxo‑13R‑manoyl oxide synthesis, do not affect ferruginol pro‑
duction, and vice versa.
The best performing variant, A99I, was utilized to reconstruct the forskolin biosynthetic pathway in yeast cells. 
Although these strains showed increased 11‑oxo‑manoyl oxide production and higher accumulation of other path‑
way intermediates compared to the native CYP76AH15, lower production of forskolin was observed.
Conclusions: As demonstrated for CYP76AH15, site‑directed mutagenesis of SRS regions of plant CYPs may be an 
efficient and targeted approach to increase the performance of these enzymes. Although in this work we have man‑
aged to achieve higher efficiency and specificity of the first CYP of the pathway, further work is necessary in order to 
increase the overall production of forskolin in yeast cells.
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Background
Many diterpenoids from the Lamiaceae (or mint) plant 
family are high-value compounds that have been used 
extensively in the food, medicine and fragrance indus-
tries. Isolation of pure diterpenoids from native plants 
is challenging due to low amounts, difficult separation 
from structurally alike compounds, and yield fluctuations 
because of environmental factors. Forskolin is a labdane-
diterpenoid produced exclusively from the Ayurvedic 
Lamiaceae plant Coleus forskohlii. The medicinal prop-
erties attributed to forskolin, from body mass control to 
glaucoma and heart failure treatment, are based on its 
ability to activate the enzyme adenyl-cyclase, which sub-
sequently increases the cellular cAMP levels [1–3]. As no 
enantioselective chemical synthesis has been achieved 
[4], a potential alternative, sustainable and readily scal-
able way to produce forskolin would be to use biotech-
nological production systems whereby the biosynthetic 
pathway is reconstructed in a heterologous host. Such 
an approach requires not only the knowledge of the bio-
synthetic steps and enzymes, but also metabolic opti-
mization of the pathway and the selected host, to reach 
industrially relevant production titers.
The biosynthetic pathway of forskolin was recently elu-
cidated [5], enabling the development of biotechnologi-
cal means for the production of this pharmaceutical. A 
Saccharomyces cerevisiae (yeast) strain expressing the 
entire forskolin biosynthetic pathway was able to pro-
duce 40 mg of forskolin per liter of yeast culture using fed 
batch fermentation [5]. Although the titers obtained were 
significant, it was still far from possible industrial appli-
cations. Nevertheless, the results obtained from these 
first experiments indicated the first promising points 
where the pathway could be optimize to increase forsko-
lin production in yeast.
Forskolin is produced in the root cork cells of C. for-
skohlii, from GGPP (geranylgeranyl diphosphate), which 
is the building block of most diterpenoids. GGPP is 
converted to 13R-manoyl oxide, the cyclic diterpenoid 
precursor of forskolin [6], by a pair of soluble plastidial 
diterpene synthase enzymes (CfTPS2 and CfTPS3). Both 
diterpene synthases (diTPSs) were highly expressed in 
the root cork cells of C. forskohlii, where forskolin accu-
mulates. CfTPS1 is an additional highly expressed root 
cork specific diTPS that in combination with CfTPS3 
gives rise to the formation of miltiradiene, a precursor of 
a different group of diterpenoids found to accumulate in 
the same tissue. Miltiradiene is a precursor for a number 
of bioactive diterpenoids, like carnosic acid and tanshi-
nones found in other Lamiaceae species [7, 8].
13R-Manoyl oxide is oxidatively decorated by three 
cytochrome P450 enzymes (CYPs), all belonging to 
the recently discovered Lamiaceae specific CYP76AH 
subfamily, resulting in the formation of deacetyl-forsko-
lin. All forskolin-related CYP76AHs were found to be 
highly expressed in the root cork cells. The last step com-
prising acetylation of deacetylforskolin to forskolin was 
found to be catalyzed by the CfACT1-8 acetyltransferase 
(Fig. 1), a member of the BAHD family [5]. The functional 
biosynthetic pathway of forskolin was efficiently reconsti-
tuted in engineered S. cerevisiae, adding to the compila-
tion of cases showing yeast as an efficient host platform 
for diterpenoid production [5, 7, 9, 10]. However, in this 
yeast strain high levels of 13R-manoyl oxide and CYP 
intermediates accumulated, indicating that the efficiency 
or specificity of the CYP catalysed reactions were com-
promising the attainment of increased titers of forskolin.
Plant CYPs are heme-binding microsomal enzymes 
typically bound to the endoplasmic reticulum (ER) mem-
brane by an N-terminal peptide-anchor, with the catalytic 
domain of the enzyme exposed to the cytosol [11]. CYPs 
are unique catalysts as they can catalyze oxygenations of 
non-activated C-atom bonds under mild conditions [12]. 
Targeted site-directed mutagenesis of membrane-bound 
plant CYPs to increase or change their catalytic proper-
ties is challenging due to the limited number of avail-
able CYP’s   crystal structures; moreover, model-guided 
approaches are hampered by low enzymes’   sequence 
identity. CYPs from all kingdoms of life share six distinct 
protein areas, or domains, known as Substrate Recogni-
tion Sites (SRS1-6). The SRS regions are part of the CYP 
active site surrounding the heme prosthetic group [13] 
and contribute to the catalytic activity, substrate recogni-
tion or substrate binding specificity. The SRS regions can 
be effectively identified and targeted for mutagenesis by 
comparing the amino acid sequences of the C. forskohlii 
CYPs with previously characterized enzymes [14–16].
Here we report the optimization of the activity and 
specificity of CYP76AH15, which catalyzes the con-
version of 13R-manoyl oxide to 11-oxo-13R-manoyl 
oxide [5]. To achieve this, a semi-rational site-directed 
mutagenesis approach targeting the six SRS domains was 
used. The activities of the obtained mutant variants were 
monitored by expressing them   in yeast cells produc-
ing 13R-manoyl oxide or miltiradiene, and  by study the 
in vivo diterpenoid accumulation.
Results
Defining the SRS regions of the C. forskohlii CYP76AH 
enzymes
The putative substrate recognition sites (SRS) of the C. 
forskohlii CYP76AH enzymes were identified by align-
ments and comparisons of reported SRSs of Rattus nor-
vegicus CYP2A1 [17], Hyoscyamus muticus CYP71D55 
[14] and Thapsia villosa CYP71AJ6 [18] (Additional file 1: 
Fig. S1). Furthermore, comparative homology modeling 
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was used to determine and visualize the SRS regions of 
CYP76AH15 (Fig. 2a) to verify that the identified regions 
corresponded to the structural elements associated with 
the respective SRSs. According to this data, CYP76AH11, 
CYP76AH15 and CYP76AH16 contain 78 residues in 
the identified SRS regions whereas CYP76AH8 and 
CYP76AH17 contain 77 residues due to a deletion of one 
amino acid in the SRS6 (Fig. 2b).
The mutagenesis efforts we implemented aimed at 
increasing the efficiency of the first putative step of the 
forskolin pathway, namely the conversion of 13R-manoyl 
oxide to 11-oxo-13R-manoyl oxide (Fig.  1). Three 
CYP76AH enzymes from C. forskohlii—CYP76AH8, 
CYP76AH15 and CYP76AH17—were previously found 
to use 13R-manoyl oxide as substrate for the synthesis 
of 11-oxo-13R-manoyl oxide (Fig.  1), which is the main 
product of these enzymes, while other related diterpe-
noids were observed as minor compounds. CYP76AH15 
was however shown to be more efficient towards the 
synthesis of 11-oxo-13R-manoyl oxide in compari-
son to its counterparts [5]. Because of the functional 
similarities observed between these enzymes, their SRS 
regions were compared to identify possible similari-
ties and differences in their primary structure (Fig.  2b). 
CYP76AH8 and CYP76AH17 share similar product pat-
terns when 13R-manoyl oxide is used as substrate and 
this is reflected also by their sequence identity which is 
88%, when the full length sequences are compared. The 
sequence identity between CYP76AH8 and CYP76AH17 
in the SRS regions is 99%, with a single amino acid dif-
ference in SRS1 (A117S, in CYP76AH17), demonstrat-
ing high sequence conservation, specifically in the 
SRS regions. Differences in the SRS regions between 
CYP76AH15 and CYP76AH8/CYP76AH17 were posi-
tioned mainly in SRS1, SRS3 and SRS6, whereas the SRS5 
was conserved between all three enzymes (Table 1).
Fig. 1 Diterpene biosynthetic pathways from the universal precursor geranylgeranyl diphosphate (GGPP) towards forskolin and ferruginol, 
compounds present in the root cork cells of Coleus forskohlii. The common diterpene precursor GGPP is formed by four  C5 units from the 
plastid based 2‑C‑methyl‑d‑erythritol 4‑phosphate pathway (MEP). GGPP is cyclized by the class II diterpene synthase (diTPS), CfTPS1, to 
(+)‑copalyl‑diphosphate and further to miltiradiene by class I diTPS, CfTPS3. Miltiradiene can undergo non‑enzymatic oxidation into abietatriene, 
which is hydroxylated to ferruginol by CYP76AH15. The forskolin precursor 13R‑manoyl oxide is formed from GGPP through (+)‑8‑hydroxy‑copalyl 
diphosphate by the class II diTPS, CfTPS2, and further to 13R‑manoyl oxide by the class I diTPS, CfTPS3. 13R‑manoyl oxide is further converted by 
CYP76AH15 to 11‑oxo‑13R‑manoyl oxide, which is further converted to 9‑deoxy‑7‑deacetylforskolin by the multifunctional CYP76AH11 and to 
deacetyl‑forskolin by CYP76AH16. Finally, deacetyl‑forskolin is acetylated at carbon 7 by CfACT1‑8 to forskolin
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CYP76AH11 and CYP76AH16, the other CYP76AHs 
involved in forskolin biosynthesis, catalyze distinct 
reactions in the pathway. CYP76AH11 is a multifunc-
tional enzyme mainly catalyzing three oxygenations, 
and CYP76AH16 is regio-specific towards C-9 hydroxy-
lation [5]. The SRS differences between CYP76AH11 
and CYP76AH16 shared a similar pattern as when 
CYP76AH8/17 are compared with CYP76AH15. The 
major differences were found in SRS1 (54% identity), 
SRS3 (50% identity) and SRS6 (63% identity). SRS5 was 
not conserved between CYP76AH11 and CYP76AH16 
(Table 1).
Reciprocal and targeted mutations of CYP76AH15
We have focused our mutagenesis efforts on areas in the 
SRS regions that could be responsible for the observed 
catalytic differences, and thus responsible for the product 
specificity. When compared to the CYP76AH enzymes, 
the highest sequence variations were observed between 
the SRS1, SRS3, and SRS6 regions. This finding led us to 
target these areas for engineering. The SRS5 region was 
also included as it had been   previously identified as a 
mutagenesis hot spot, especially the residues located 5 
and 9 amino acids upstream of the conserved ExxR motif 
[19]. Additionally, we targeted specific residues of the 
CYP76AH15 that corresponded to structurally equiva-
lent positions with ones that have been found to increase 
a b
Fig. 2 The SRS regions of selected CYP76AHs from Coleus forskohlii. a Homology model of CYP76AH15 with visualized SRS regions and selected 
helix‑letters. SRS1, blue (left); SRS2, blue (right); SRS3, red (top); SRS5, green (bottom); and SRS6, red (right) were chosen as targeted areas for 
mutagenesis. The position of SRS4 on αI is shown in green. b Sequence alignments of the defined SRS regions of selected CYP76AH enzymes. Sites 
for mutagenesis are highlighted: Red; previously identified sites in other CYPs shown to confer changes in CYP properties (e.g. the SRS5 residues) or 
residues chosen in this work due to their structural positions. Green; sites of reciprocal mutagenesis of CYP76AH15 in comparison to CYP76AH8
Table 1 Sequence identity comparisons of  the  SRS regions of  selected CYP76AHs as  well as  of  the full-length protein 
sequences
Aligned SRS1 (%) SRS2 (%) SRS3 (%) SRS4 (%) SRS5 (%) SRS6 (%) Total SRS (%) Total 
sequence 
(%)
AH15 and AH8 79 88 75 89 100 50 82 87
AH15 and AH17 75 88 75 89 100 50 81 80
AH8 and AH17 96 100 100 100 100 100 99 88
AH11 and AH16 54 88 50 89 82 63 71 76
AH15 and AH11 46 25 50 42 82 25 46 51
AH15 and AH16 50 25 25 47 82 25 46 54
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activity or specificity, when subjected to mutagenesis 
in other plant CYPs. We furthermore used reciprocal 
mutagenesis with residues from CYP76AH8 to gain 
insights into the catalytic differences between the two 
enzymes (CYP76AH8 versus CYP76AH15).
Residue A99 was targeted as it was found to be struc-
turally equivalent to position L123 in CYP720B1 (Addi-
tional file  1: Fig. S2), which was shown to increase 
diterpene turnover in yeast, when subjected to mutagen-
esis [20]. Mutations of Y236 (in SRS3) alone and in com-
bination with S235 were chosen as both residues are 
situated at the N-terminal of the αG helix pointing out-
wards, according to the homology model (Fig. 2a), in an 
area which is suggested to be close to the ER membrane, 
in membrane-anchored CYPs [21, 22]. Residues G362 (5 
residues from ExxR) and L366 (9 residues from ExxR) 
from SRS5 domain, were chosen for mutagenesis as 
both pointing towards the heme moiety of CYP76AH15 
(Fig.  2). Mutations of structurally equivalent positions 
had previously yielded plant CYPs variants with altered 
catalytic characteristics [14–16, 20]. The targeted SRS6 
residues were chosen, because according to previous 
studies, mutagenesis in this area had been found effective 
[23].
CYP76AH15 SRS variants showing increased levels 
of 11‑oxo‑13R‑manoyl oxide
Mutants were generated using the USER system as 
described in the Methods section. The generated 
CYP76AH15 variants were integrated into the genome 
of the previously reported EYS4498 yeast strain produc-
ing 13R-manoyl oxide (1), together with the cytochrome 
P450 oxidoreductase (POR) from C. forskohlii, CfPOR 
(Table  2). Our initial screening efforts were conducted 
with yeast cells growing in microtiter plates, allow-
ing easy handling and screening of high numbers of 
CYP76AH15 mutant variants.
The control yeast strain (MO (−), harboring genome 
integrated CfPOR, no CYPs) was shown to accumulate 
13R-manoyl oxide (1), when hexane extracts from yeast 
cells and broth were analyzed by GC–MS (Fig. 3a). The 
diterpenoids produced from strains harboring genome 
integrated native CYP76AH15 or mutant variants 
(Table  3, Additional file  1: Table  S1) were analysed by 
GC–MS. Expression of CYP76AH15 led to the forma-
tion of 11-oxo-13R-manoyl oxide (2), 11β-hydroxy-13R-
manoyl oxide (3) and an unknown compound (7) with a 
m/z 320 (Fig. 3e), which according to its molecular mass, 
could be an oxo-hydroxy-13R-manoyl oxide compound. 
Several CYP76AH15 mutant variants resulted in signifi-
cant increase of 11-oxo-13R-manoyl oxide (2) (Fig.  3). 
More precisely, these variants were the A99I (SRS1), 
S235G-Y236F (SRS3), L366F and L366E (both in SRS5). 
Variant A99I displayed a 5.6-fold increase in accumu-
lated 11-oxo-13R-manoyl oxide (2) while the levels of 
13R-manoyl oxide (1) dropped significantly (P < 0.05, 
T-test) compared to the native CYP76AH15 (Fig.  3b). 
The variant A99I displayed no detectable levels (or trace 
amounts) of compound 7, suggesting that this change 
resulted in an enzyme with a more specific activity 
towards the formation of 11-oxo-13R-manoyl oxide (2), 
although amounts of 13R-manoyl oxide (1) as well as of 
compound 11β-hydroxy-13R-manoyl oxide (3) could still 
be detected (Fig. 3b). 
CYP76AH15 variants with altered product patterns
Among the generated CYP76AH15 variants with muta-
tions at the SRS5 and SRS6 (Table  1, Additional file  1: 
Table S1), three variants were found to produce consid-
erably different product patterns when compared to the 
native CYP76AH15. Two of them were within the SRS5, 
namely G362V and G362V L366F and one in SRS6, the 
deletion 473DDP::EL (Fig. 3d). Variant G362V produced 
small amounts of 11β-hydroxy-13R-manoyl oxide (3), 
while the double variant G362V L366F produced mainly 
11β-hydroxy-13R-manoyl oxide (3) with trace amounts 
of 11-oxo-13R-manoyl oxide (2). The 473DPP::EL 
variant displayed a change in product pattern, as it 
Table 2 Yeast strains utilized and generated in this study
Strain Genotype Source
S288C MATα, SUC2, gal2, mal2, mel, flo1, flo8‑1, ho, bio1, bio6, ura3Δ Evolva  
A/S
EFSC4498 S288C, XI‑2::(pPGK1‑CfTPS3/pTEF1‑CfTPS2/pTPI1‑SpGGPPS7), ura3Δ Evolva  
A/S
MO (−) YFSC4498, XI‑5::(pTEF2‑CfPOR/URA3) This work
MO‑AH15 YFSC4498, XI‑5::(pTDH3‑CYP76AH15/pTEF2‑CfPOR/URA3) This work
MILT S288C, XI‑2::(pPGK1‑CfTPS3/pTEF2‑CfTPS3/pTPI1‑SpGGPPS7), ura3Δ This work
MILT (−) MILT, XII‑5::(pTEF2‑CfPOR/URA3) This work
MILT‑AH15 MILT, XI‑5::(pTDH3‑CYP76AH15/pTEF2‑CfPOR/URA3) This work
FORSK EFSC4498, X‑3::(pTEF2‑CfPOR/pFBA1‑CYP76AH15/pSED1‑CYP76AH11/pTDH3‑CYP76AH16/pTEF2‑
CfACT1‑8/URA3)
This work
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produced significantly (P < 0.05, T-test) higher levels of 
the unknown compound 7, while maintaining similar lev-
els of 11-oxo-13R-manoyl oxide (2) when compared to 
the native enzyme (Fig. 3d).
CYP76AH15 combinatorial mutagenesis with synergistic 
and antagonistic effects
After demonstrating that the change of a single resi-
due in CYP76AH15 can cause a substantial effect in 
the enzyme’s product profile, we next sought to study 
a b c
d e
Fig. 3 Diterpenoid product profiles from the CYP76AH15 mutant variants, in comparison to the native enzyme when expressed in yeast 
cells producing 13R‑manoyl oxide (MO). a GC–MS chromatograms of the control strain MO (−) with CfPOR only, and strains from CYP76AH15 
mutant‑variants at the SRS1, SRS3 and SRS5 regions showing enhanced production of 11‑oxo‑13R‑manoyl oxide (2). b Relative yields of the 
diterpenes 1 (red bars), 2 (green bars), 3 (light purple bars) and unknown 7 (light pink bars). The yeast strains expressing the SRS1, SRS3 and SRS5 
variants of CYP76AH15 produced significantly higher levels of 2 and 3 and lower levels of 7, in comparison to the native enzyme. c Chemical 
structures of the identified products formed by yeast. d GC–MS chromatograms of the control strain MO (−) with CfPOR only, native CYP76AH15, 
SRS5 and SRS6 mutated variants, and 11β‑hydroxy‑MO as internal standard (STD). e MS spectrum of (7) with parent ion m/z 320. IS internal standard 
(1 mg/L 1‑eicosene), MO 13R‑manoyl oxide, TIC total ion chromatogram. Error bars indicate standard deviation from three biological replicates
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the effect of combinatorial mutagenesis using the vari-
ants already tried from SRS1, SRS3 and SRS5 (Table 3), 
which resulted in increased formation of 11-oxo-13R-
manoyl oxide (2). Combination of the mutations A99I, 
S235G and Y236F (SRS1 + SRS3) led to a variant able to 
accumulate 6.5 times more 11-oxo-13R-manoyl oxide 
(2) in comparison to the native CYP76AH15, indicat-
ing a synergistic effect of these mutations. Similarly, 
when the mutations A99I and L366F (SRS1 + SRS5) were 
combined, an increase of 6.2-fold was observed. The 
combination of A99I and L366E (SRS1 + SRS5) muta-
tions resulted in an inactive enzyme. Combination of 
the mutations S235G, Y236F and L366E (SRS3 + SRS5) 
resulted in a 3.1-fold increase in the accumulation of 
11-oxo-13R-manoyl oxide (2) in comparison to the 3.7-
fold increase obtained with the L366E variant alone, 
indicating a slightly antagonistic effect. The combi-
nation of mutations A99I, S235G, Y236F and L366F 
(SRS1 + SRS3 + SRS5) offered a 3.2-fold increase in the 
production of 11-oxo-13R-manoyl oxide (2), again dem-
onstrating a slightly antagonistic effect of the combined 
mutations. The combined mutations of A99I S235G 
Y236F L366E resulted in an inactive enzyme. A summary 
of the results from the screening of the mutant variants 
is shown at Additional file 1: Table S1. The combinatorial 
variants were also studied for their capacity to produce 
11β-hydroxy-13R-manoyl oxide (3) as it is also a prod-
uct of the native CYP76AH15. It was shown that besides 
affecting the formation of 11-oxo-13R-manoyl oxide (2) 
some of these variants resulted in a dramatic increase 
in the formation of 11β-hydroxy-13R-manoyl oxide (3). 
Variant A99I S235G Y236F L366F for example showed 
31.4-fold increase regarding 11β-hydroxy-13R-manoyl 
oxide (3), indicating that the ability of this enzyme to 
actively catalyze the formation of ketone group in carbon 
11 has been slightly shifted. Interestingly, the variant 
A99I contained the lowest change regarding accumula-
tion of 11β-hydroxy-13R-manoyl oxide (3) and one of the 
highest increase observed regarding the accumulation of 
11-oxo-13R-manoyl oxide (2) (Table 3).
CYP76AH15 SRS6 variants towards miltiradiene conversion
CYP76AH15 was previously shown to be multifunc-
tional as it not only produces 11-oxo-13R-manoyl oxide 
(2) from 13R-manoyl oxide (1) but also ferruginol, when 
miltiradiene is supplied as substrate [5]. We therefore 
investigated the effects of the generated CYP76AH15 
mutants (Additional file  1: Table  S1) regarding their 
catalytic activity towards ferruginol, in the presence of 
miltiradiene.
A yeast strain producing miltiradiene (4) was con-
structed to explore first if CYP76AH15 facilitates the for-
mation of ferruginol (6) in yeast, as it had previously been 
observed by transient expression in tobacco and if the 
generated mutations would affect ferruginol formation. 
The control yeast strain, {MILT (−)}, expressing CfPOR 
and no CYPs, was able to produce two compounds, 
miltiradiene (4) and abietatriene (5) (Fig.  4a). Expres-
sion of the native CYP76AH15 together with CfPOR led 
to formation of compound 6, which matched the reten-
tion time and spectrum of ferruginol (Fig. 4a). From the 
mutants expressed in MILT (−) strain, only the SRS6 
variants F476T and L478M/I/A showed increased pro-
duction of ferruginol (6), with the highest ones observed 
from F476T and L478A giving a 2.4-fold increase 
(Fig.  4b). Interestingly, these variants did not affect the 
formation of 11-oxo-13R-manoyl oxide (2). The vari-
ants A99I, S235G, Y236F, L366F and L366E that showed 
improved formation of 11-oxo-13R-manoyl oxide (2) 
when supplied with 13R-manoyl oxide, showed lowered 
production of ferruginol (6) (Additional file 1: Table S1), 
indicating that these specific changes were specifically 
affecting the formation of 11-oxo-13R-manoyl oxide (2) 
but not of ferruginol (6).
Improved CYPs efficiency in yeast strains growing 
in shake‑flasks
When comparing the remaining 13R-manoyl oxide (1) 
in strains expressing the native CYP76AH15 and the 
mutants, the levels of (1) were similar, despite the dif-
ferences observed at the individual CYP products, when 
yeast strains were grown in microtiter plates. Since the 
yeast growth environment could affect the efficiency of 
CYPs, we explored if changes in growth conditions could 
improve CYPs’ performances. Thus, we utilized shake-
flasks instead of microtiter plates as they offer improved 
oxygenation conditions. Yeast strains expressing selected 
CYP76AH15 variants, including the native enzyme, were 
Table 3 Production levels of  11-oxo-13R-manoyl oxide 
(2) and  11-hydroxy-13R-manoyl oxide (3) by  CYP76AH15 
variants with  SRS mutations using microtiter plates 
for yeast growth
a Fold change of products 2 and 3, respectively, compared to native CYP76AH15
Variant SRS site(s) 2a 3a
Native CYP76AH15 – 1 1
A99I 1 5.6 3.0
S235G Y236F 3 5.1 7.3
L366F 5 2.9 4.2
L366E 5 3.7 6.2
A99I S235G Y236F 1 + 3 6.5 14.2
A99I L366F 1 + 5 6.2 4.9
S235G Y236F L366E 3 + 5 3.1 16.5
A99I S235G Y236F L366F 1 + 3+5 3.2 31.4
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grown in shake-flasks while in vivo production of diter-
penoids was monitored over 72 h (Fig. 5, Table 4).
Production of 13R-manoyl oxide (1) in the MO (−) 
control yeast strain stagnated after 48  h at approxi-
mately 43  mg/L, with a final titer of 43.8  mg/L after 
72  h. The product of the native CYP76AH15 followed 
a similar pattern with stagnation in diterpene produc-
tion after 48 h and a final total diterpene production of 
43.8 mg/L while only a 64% fraction of diterpenoids was 
oxygenated (compounds 2, 3 and 7). The production of 
11-oxo-13R-manoyl oxide (2) followed a similar stagna-
tion pattern and reached 23.4 mg/L after 72 h, account-
ing for 53% of the total diterpene content. Introduction 
of selected variants resulted in a different production 
pattern with no stagnation regarding the accumulation 
of 11-oxo-13R-manoyl oxide (2), for all variants tested. 
The A99I variant showed a two-fold increase in total 
amounts of diterpenes (87.7  mg/L) compared to the 
native CYP76AH15 (43.8 mg/L) of which production of 
11-oxo-13R-manoyl oxide (2) was 3.7-fold higher and 
accounting for 99% (86.4 mg/L) of the total diterpenoids. 
Levels of 13R-manoyl oxide (1) were nearly depleted with 
0.9 mg/L remaining, a value 18-fold lower than when the 
native CYP76AH15 was used.
An increased accumulation of 11-oxo-13R-manoyl 
oxide (2) was observed from all the variants tested and 
accounted for > 93% of the total diterpene content for five 
of them (A99I, S235G Y236F, L366F, A99I S235G Y236F 
and A99I L366F). The titers were at least 3 times higher 
and reaching > 70  mg/L in three variants (A99I, S235G 
L236F and A99I S235G Y236F). The relative   increase 
observed regarding the accumulation of 11-oxo-13R-
manoyl oxide (2) was generally lower in shake-flasks 
compared to microtiter experiments e.g. with the A99I 
S235G Y236F variant affording 6.5-fold increased levels 
in microtiter plates while a 3.1-fold increase in shake-
flasks, compared with native CYP76AH15.
Production of forskolin in yeast strains expressing native 
CYP76AH15 or A99I
We next sought to explore the effect that engineered 
CYP76AH15 variants could have on forskolin produc-
tion. For the trials, the A99I mutant variant was selected 
as it showed the highest levels of 11-oxo-13R-manoyl 
oxide (2) while maintaining low levels of 13R-manoyl 
oxide (1), 11β-hydroxy-13R-manoyl oxide (3) and 7. The 
forskolin biosynthetic genes, CYP76AH11, CYP76AH15, 
CYP76AH16, CfACT1-8 and CfPOR were integrated 
into the genome of the strain EYS4498, in the X-3 locus. 
The generated strains were grown in baffled shake-flasks 
to maximize oxygen availability. Diterpene production 
in  vivo was monitored after 72  h by both GC–MS and 
LC–MS (Fig. 6, Table 5).
Strains expressing the full forskolin pathway, with the 
native CYP76AH15 (FORSK AH15) or the CYP76AH15 
A99I variant (FORSK A99I) showed production of 1, 2, 
3, 9-hydroxy-13R-manoyl oxide (8), forskolin (9) as well 
as several putative unidentified forskolin-intermedi-
ates (a, b and c). Yeast cells harboring the A99I mutant 
showed 2.1-fold increased production of 2 and decreased 
a b
c
Fig. 4 Effect of CYP76AH15 mutants on the synthesis of ferruginol in miltiradiene producing yeast strains. a GC–MS chromatograms of control 
MILT(−) strains expressing CfTPS1, CfTPS3 and CfPOR able to produce miltiradiene (4) and abietatriene (5). Expression of native CYP76AH15 lead to 
production of 6 which corresponds to ferruginol according to its comparison with an authentic standard (STD), retention time and fragmentation 
pattern. b Enhanced production of 6 from CYP76AH15 mutants, altered in the SRS6 region. c Chemical structures of the identified products 
produced by the yeast strains mentioned in a 
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levels of 1 (Table  5), indicating a higher turnover of 
13R-manoyl oxide by the A99I mutant compared to the 
native enzyme. The peaks of compounds a, b and c var-
ied between FORSK AH15 and FORSK A99I (Table  5). 
Intermediate a was lower in FORSK A99I strain, whereas 
the intermediates b and c were 3.3 and 22.7-fold higher, 
respectively, compared to strain FORSK AH15. Forskolin 
production (9) was however 50% lower in strains express-
ing A99I compared to the native CYP76AH15 sequence. 
FORSK AH15 strains produced a final titer of 1.3 mg/L 
(± 0.12  mg/L) of forskolin whereas FORSK A99I pro-
duced 0.7 mg/L (± 0.01 mg/L) of forskolin.
Fig. 5 Production titers of 1 (red line), 2 (green line), 3 (purple line) and non‑identified oxo‑hydroxy‑13R‑manoyl oxide (7) (pink line, WT CYP76AH15 
only) produced by engineered yeast strains expressing CfTPS2, CfTPS3, CfPOR and either wild type or selected mutant‑variants of CYP76AH15, 
grown in shake‑flasks
Table 4 Production titers of  13R-manoyl oxide (1), 11-oxo-13R-manoyl oxide (2) and  11-hydroxy-13R-manoyl oxide (3) 
by CYP76AH15 variants with SRS mutations using shake-flasks for yeast growth
Name Total mg/L Oxygenated (%) 1 mg/L 2 mg/L 3 mg/L Content 
of 2 (%)
MO (−) 43.8 0 43.8 0.0 0.0 0
WT CYP76AH15 43.8 64 15.9 23.4 0.2 53
A99I 87.7 99 0.9 86.4 0.4 99
S235G Y236F 73.5 94 4.1 68.6 0.8 93
L366F 68.2 96 3.1 64.7 0.5 95
L366E 69.2 90 7.0 61.2 1.0 88
A99I S235G Y236F 83.4 97 2.2 79.8 1.4 96
A99I L366F 75.8 96 2.8 72.6 0.4 96
S235G Y236F L366E 47.1 80 9.6 34.2 3.3 73
A99I S235G Y236F L366F 59.6 83 10.2 44.2 5.1 74
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Discussion
Synthesis of the diterpene hydrocarbon backbones 
found in nature, such as 13R-manoyl oxide, is catalyzed 
by diterpene synthases. Production of these diterpenoid 
backbones can be achieved by heterologous expres-
sion of the relevant diterpene synthases in engineered 
yeast affording titers of more than 300 mg/L [9, 24, 25]. 
The structurally diverse backbones are then subjected to 
regio-selective functionalization by oxygenation reactions 
catalyzed by CYPs. CYPs are heme-containing enzymes 
found in all biological kingdoms. The primary sequences 
of CYPs are highly variable but their core protein fold is 
conserved from microbes to plants and consists of five 
β-sheets (named 1–5) and 13 α-helices (named αA–αL). 
SRS (substrate recognition sites) regions that span all 
CYP peptides have been assigned as important domains 
a b
c
Fig. 6 Production of forskolin and intermediates in yeast strains expressing native CYP76AH15 or the A99I  mutant  variant. a GC–MS 
chromatograms of the control strain MO (−) expressing CfPOR only, FORSK AH15 and FORSK A99I yeast strains expressing either native CYP76AH15 
or A99I, respectively, together with the rest of the forskolin biosynthetic genes (CYP76AH11, CYP76AH16, CfACT1‑8 and CfPOR). FORSK A99I showed 
increased accumulation of 2, 3 and the unidentified intermediates b and c, whereas production of 1, 8 and a was lowered compared to FORSK 
AH15. b Relative extracted ion chromatograms corresponding to [M+H]+ of forskolin at m/z 411.2381 ± 0.05 by LC–MS analysis. The analysis 
showed lowered production of forskolin in the strain FORSK A99I compared to FORSK AH15. c Identified products on GC–MS and LC–MS. IS internal 
standard (10 mg/L 1‑eicosene), MO 13R‑manoyl oxide, TIC total ion chromatogram, EIC extracted ion chromatograms
Table 5 Relative diterpene yields in forskolin strains
nd not detected
Strain 1 2 3 8 9 a b c
MO (−) 4.1 nd nd nd nd nd nd nd
FORSK AH15 1 1 nd 1 1 1 1 1
FORSK A99I 0.5 2.1 – 0.2 0.5 0.3 3.3 22.7
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for substrate recognition and catalytic activity [13, 17]. 
In contrast to the diterpene synthases, CYPs are mem-
brane bound enzymes, thus their  efficient expression in 
heterologous microbial systems is often challenging [4, 
7, 10] and usually requires careful and complex optimi-
zation [26]. In bioengineering projects, CYP catalysed 
steps are likely to be rate-limiting. Additional challenges 
are imposed when it comes to the expression of multi-
steps pathways, often consisting of more than one pro-
miscuous CYP, as reported for the carnosic acid pathway 
containing two CYPs [7] or for the forskolin pathway 
containing three CYP enzymes [5]. Due to the important 
and unique catalytic activities of CYPs, several strategies 
have been adopted to improve or alter their performance 
[27–29]. It is believed that the ability of CYPs to tolerate 
engineering and still maintain their catalytic activities, 
originates from the non-polar residues in their active 
sites. The weak van der Waals force-interactions between 
the non-polar residues found at the catalytic pockets of 
these enzymes facilitate this phenomenon. In contrast, if 
stronger forces, such as hydrogen bonds or salt bridges, 
are altered between charged amino acids, this could eas-
ily negatively affect the protein stability and overall fold-
ing of enzymes [28].
Mutagenesis studies on membrane bound plant CYPs 
have been largely carried out in vitro and the functional 
changes observed mainly affected regio-specificity [15, 
16], substrate specificity and catalytic efficiency [14]. In 
the present study, we have chosen to perform our experi-
ments in vivo, because of the large differences observed 
between results obtained from in  vivo versus in  vitro 
experiments, as for example for the diterpene taxadiene-
5α-hydroxylase in yeast [30]. In plant terpenoid metabo-
lism, engineering of CYP720B1 (PtAO) and heterologous 
expression of the variants in yeast, resulted in increased 
accumulation of the enzyme’s product as well as in 
changes in substrate specificity and product profiles [31]. 
However, to utilize directed mutagenesis as a standard-
ized tool for CYP optimization and directed outcomes, 
more precise knowledge is needed regarding regions and 
residues that could affect the functional properties of the 
enzyme.
Mutation strategies based on directed-evolution by 
error-prone PCR or DNA shuffling require a labor inten-
sive screening of large libraries of CYP variants [27]. 
In the work described here, semi-rational engineer-
ing of SRS regions of CYP76AH15 from C. forskohlii 
was carried out to identify specific residues that dictate 
product specificity and enzyme efficiency, with the ulti-
mate experimental goal to increase in  vivo formation 
of the forskolin precursor 11-oxo-13R-manoyl oxide 
(2) in yeast. The activity of the generated CYP76AH15 
variants was monitored by expressing them in yeast 
cells, engineered to produce the enzyme’s substrate, 
13R-manoyl oxide, and identify and quantify the pro-
duced diterpenoids. In previous targeted studies on 
mutagenesis of plant CYPs, residues have been chosen 
according to their position in relation to heme, i.e. resi-
dues defining the cavity enclosing the heme-containing 
catalytic pocket of the enzyme [14, 16, 32]. This approach 
reduces the number of residues targeted for mutation 
making it easier to accomplish, but it has the risk to miss 
residues with profound effect on the catalytic activity. 
In our current study, homology modelling demonstrates 
that the A99I mutation in SRS1 and the mutations S235G 
Y236F in SRS3 are positioned ~ 18Å and ~ 25Å away from 
the heme–iron atom, respectively (Fig. 2a). Moreover, the 
S235 and Y236 side chains are pointing outwards away 
from the heme, according to our homology models. The 
A99I and S235G Y236F mutations gave the most pro-
found increase in 11-oxo-13R-manoyl oxide (2) produc-
tion. These residues may play an important role in the 
orientation of 13R-manoyl oxide (1) in the enzymatic 
cavity and thus force exclusive oxygenation of carbon 
11 leading to increased synthesis of 11-oxo-13R-manoyl 
oxide (2) (Fig.  3). These residues would not have been 
selected for mutagenesis based strictly on criteria regard-
ing their position relative to heme. Other mutagenesis 
studies have been based on substitution of amino acids 
with other counterparts bearing similar properties [31], 
like the case of A99I mutation where both amino acids 
(A, alanine and I, isoleucine) are lipophilic. However, this 
is not the case with the L366E or S235G Y236F substitu-
tions, where a lipophilic amino acid is replaced with an 
acidic (L366E), or polar amino acids  are substituted with 
lipophilic  ones (S235G Y236F). Interestingly, the latter 
substitutions provided higher enzyme efficiency, but not 
necessarily specificity (Table 3).
In microtiter plate experiments, the A99I mutation in 
SRS1 was responsible for the highest increase in the pro-
duction of 11-oxo-13R-manoyl oxide (2) and showed the 
highest product specificity (Fig. 3). In shake-flask experi-
ments, the mutation enabled nearly full conversion of 
13R-manoyl oxide (1) into 11-oxo-13R-manoyl oxide (2), 
(Fig. 5; Table 4). Residue A99 was targeted for mutagen-
esis because it is positioned in a structurally equivalent 
position to L123 in CYP720B1 (Fig. S2), which was previ-
ously shown to facilitate significant increase in produc-
tion of oxygenated diterpenoids in yeast [31]. Both A99 
in CYP76AH15 and L123 in CYP720B1 are positioned 
in the first turn of αB′ (Fig. 2) pointing inwards towards 
the heme cavity, suggesting that residues in this particu-
lar position are important for the catalytic properties 
of CYPs and could thus be effective targets for future 
mutagenesis studies. The ability of CYP76AH15 to syn-
thesize ferruginol (6) was reduced by the A99I mutation 
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(Additional file  1: Table  S1), suggesting that the muta-
tion altered product specificity by changing the enzy-
matic cavity and the way the enzyme interacts with its 
substrates.
In microtiter plates, the double mutation S235G Y236F 
in SRS3 afforded a 5.2-fold increase in the formation of 
11-oxo-13R-manoyl oxide (2) (Table  3). In shake-flask 
conditions, the S235G Y236F mutation increased the 
oxygenation levels of 13R-manoyl oxide (1) with the 
majority being transformed into 11-oxo-13R-manoyl 
oxide (2), (93% content of 2), (Table  4). The S235 and 
Y236 residues in SRS3 are positioned in the N-terminal 
of the αG (Fig. 2) and in the loop connecting αF′ and αG, 
a region that has been suggested to be directly interact-
ing with the lipid bilayer [21, 22, 33]. The S235G Y236F 
mutations may facilitate the access of the substrate in 
the catalytic cavity through the membrane, because 
13R-manoyl oxide is a highly lipophilic substrate and 
SRS3 together with SRS2 form the entrance channel 
towards the heme, through the lipid bilayer [13, 21, 22]. 
Mutagenesis of structurally equivalent positions in other 
plant CYPs has not been reported to our knowledge. It 
thus remains to be investigated whether SRS3 mutagen-
esis at these positions affects other plant CYPs using dif-
ferent substrates. The S235G Y236F variant retained the 
activity towards ferruginol (6) production (Additional 
file  1: Table  S1) at levels similar to the native enzyme, 
suggesting that S235GY236F specifically affected conver-
sion of 13R-manoyl oxide (1) into oxo-13R-manoyl oxide 
(2).
Specific changes in SRS5 led to an increase in the accu-
mulation of either 11-oxo-13R-manoyl oxide (2) (L366F 
and L366E) or 11β-hydroxy-13R-manoyl oxide (3), 
(G362V and G362VL366F), the latter mutation result-
ing in an altered product profile. Thus, by changing resi-
dues in SRS5 it is possible to obtain CYP76AH15 variants 
with different functional properties ranging from specific 
producer of 11-oxo-13R-manoyl oxide (2) to a dedicated 
11β-hydroxy-13R-manoyl oxide (3) synthase (Fig. 3). The 
G362V and L366E mutations are positioned five (G362) 
and nine (L366) residues from the conserved ExxR motif 
and are located in SRS5 positions known to be muta-
tional “hotspots” [19]. Mutations in these positions have 
previously been shown to change the catalytic properties 
of plant CYPs [15, 16, 34]. Our study thus substantiates 
that these residues play a critical role in CYP functional 
properties.
Reciprocal mutations in the SRS6 region of the 
CYP76AH15 were guided by sequence-comparisons 
between the CYP76AH15 and CYP76AH8 enzymes. 
The 473DPP::EL variant showed increased formation of 
7, a product with a mass corresponding to oxo-hydroxy-
13R-manoyl oxide (Fig.  3d). This result suggested that 
additions or deletions of residues represents an under-
explored mutagenesis approach that could alter the 
catalytic properties of CYPs. Different mutations in the 
same region (like the F476T and L478  M/I/A) signifi-
cantly increased the activity of CYP76AH15 towards 
the synthesis of ferruginol (6) when miltiradiene (4) 
is supplied as a substrate (Fig. 4). These mutations did 
not affect the activity of the enzyme when 13R-manoyl 
oxide (1) was used as substrate. This suggests that the 
altered amino acid residues at these positions may 
change the enzymatic cavity in a way that enables the 
additional docking of miltiradiene, as a substrate, with-
out disruption of the binding site for 13R-manoyl oxide.
The generation of double or triple CYP76AH15 
mutants by combining mutations in residues that have 
shown an increased enzymatic activity, resulted in syner-
gistic as well as antagonistic effects and in one case even 
a catalytically impaired enzyme. The A99I S235G Y236F 
(SRS1 and SRS3) variant resulted in 6.5-fold higher 
amounts of 11-oxo-13R-manoyl oxide (2) and a simul-
taneous 14.2-fold increase of 11β-hydroxy-13R-manoyl 
oxide (3). A similar observation was made with the A99I 
L366F (SRS1 and SRS5) variant whereas the A99I L366E 
variant was inactive (Additional file 1: Table S1).
The relative   increase of 11-oxo-13R-manoyl oxide (2) 
production from CYP76AH15 mutants was observed 
to be lower when the yeast cells were growing in shake-
flasks compared to microtiter plates. In parallel, lower 
levels of remaining 13R-manoyl oxide was observed in 
shake-flasks, indicating that the metabolic conversion 
of 13R-manoyl oxide (1) to 11-oxo-13R-manoyl oxide 
(2) was increased under these conditions when com-
pared to microtiter plates. Increased oxygen levels in 
the flask cultures may explain this observation. This was 
especially obvious with the variants A99I, A99I S235G 
Y236F and A99I L366F that all showed at least fivefold 
increase in production of 11-oxo-13R-manoyl oxide (2) 
in microtiter plates whereas only threefold increase was 
obtained in shake-flasks. At the same time, the remain-
ing 13R-manoyl oxide (1) in shake-flask cultures carrying 
strains with mutant-variants was more than five times 
less when compared with the residual levels of (1) from 
cultures with native CYP76AH15. For the A99I variant, 
particularly low residual amounts of 13R-manoyl oxide 
(< 1 mg/L) were observed, practically showing full turno-
ver of 13R-manoyl oxide (1) to 11-oxo-13R-manoyl oxide 
(2). Strains harboring the optimized CYP76AH15 vari-
ants were therefore most likely substrate-limited under 
shake-flask conditions, which may have hindered higher 
final product titers. Previous studies have reported 
reduced yields of yeast-produced diterpenoids when 
moving from smaller to larger volume cultures mainly 
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due to limited CYP activity, which is contrary to our find-
ings [35].
Our analysis of the CYP76AH15 SRS variants reported 
here show that modifications of even a single amino acid 
residue can result in significant changes of the enzyme’s 
catalytic properties. The changes may be accompa-
nied by a more narrow product profile such as exclu-
sive formation of 11-oxo-13R-manoyl oxide (2) by the 
A99I variant or 11β-hydroxy-13R-manoyl oxide (3) by 
the G362VL366F variant (Fig.  3 and Additional file  1: 
Table S3). Interestingly, all the above functional variants 
were located in three out of the six SRS domains, namely 
SRS1, SRS3 and SRS5 (Table 3). Other studies have also 
reported that mutagenesis in SRS domains may lead to 
enzymes with improved or altered functional properties 
[13, 14, 31].
To study how the generated mutants can affect forsko-
lin production, the entire forskolin biosynthetic pathway 
was reconstructed in yeast. Two different yeast strains 
producing forskolin were generated, the FORSK-AH15 
(as control) which expresses the native CYP76AH15, 
together with all native forskolin biosynthetic enzymes, 
and the FORSK-A99I which expresses the mutant A99I 
instead of the native CYP76AH15. After 72 h of growth 
in shake-flasks, total diterpenoids were extracted 
from the two strains. It was shown that although the 
improved activity of mutant A99I towards synthesis 
of 11-oxo-13R-manoyl oxide (2), which is a pathway 
intermediate, the overall forskolin yield was lower by 
approximately 50% compared to the strain expressing 
the native CYP76AH15. We did, however, observe 2.1-
fold higher accumulation of 11-oxo-13R-manoyl oxide 
(2) and lower accumulation of 13R-manoyl oxide (1), 
suggesting that the introduced A99I variant did indeed 
increase the turnover of the first step towards forsko-
lin, which was our overall goal. In parallel our results 
show that the excess accumulation of compound 2 could 
not be used efficiently from the downstream enzymes 
(CYP76AH11 and CYP76AH16). The increased turnover 
of 13R-manoyl oxide (1) to 11-oxo-13R-manoyl oxide (2) 
did not result in higher flux towards the final production 
of forskolin, which could be caused by several factors: 
(i) the downstream performance of the remaining CYPs 
(CYP76AH11 and CYP76AH16) did not accommodate 
the increased accumulation of 11-oxo-13R-manoyl oxide, 
thus leading to a buildup of intermediates such as the 
unidentified compounds (b) and (c). The increased accu-
mulation of 11-oxo-13R-manoyl oxide (2) might interfere 
with the activity of the downstream CYPs (feedback regu-
lation or levels of accumulated 11-oxo-13R-manoyl oxide 
have reached the downstream enzymes saturation level). 
(ii) The native CYP76AH15 sequence has an unidenti-
fied role in the remaining hydroxylations of (2) towards 
forskolin. This role could be limited after the introduction 
of the A99I mutation. The native CYP76AH15 enzyme 
does indeed have the capability to hydroxylate (2) into 
compound (7), which might be a crucial intermediate 
towards forskolin and the substrate of one of the down-
stream CYPs. This could be investigated by incorporation 
of a native CYP76AH15 sequence in the FORSK A99I 
strain or the 473DPP::EL mutant that showed increased 
production of (7). At present, the exact order of hydroxy-
lations towards forskolin remains unknown and because 
of the multifunctional nature of the involved CYPs, it is 
not clear which enzyme is responsible for each hydroxy-
lation. For example, CYP76AH11 was been shown to be 
able to produce deacetylforskolin, by itself, nevertheless 
in very small amounts, when expressed in tobacco. It is 
possible that the multifunctionality observed in forsko-
lin biosynthetic CYPs could be critical for maintaining 
the optimal flux through the pathway, for high forskolin 
synthesis. (iii) According to Laursen et  al., [36], meta-
bolic pathways, especially those that involve membrane 
bound enzymes like CYPs, can form metabolons (multi-
enzymatic assemblies or complexes) which facilitate the 
pathway flux or product channeling, for optimizing path-
way efficiency. It is possible that by changing the prod-
uct profile of CYP76AH15 (and possibly other unknown 
properties, at the same time) we have interfered with the 
formation or stoichiometry of the forskolin metabolon, 
which in turn has disturbed the flux of the pathway. It is 
always challenging to reconstitute multi-enzymatic path-
ways and mimic the native conditions when using het-
erologous systems, different cell compartmentalization 
or heterologous gene regulatory elements (promoters). 
In cases like this, where we add an additional complex-
ity to the system, like engineered enzymes, the balance 
and equilibrium of the pathway can be easily perturbed. 
This is an example that shows the very delicate design of 
biosynthetic pathways in nature and the difficult task of 
systems biology to unravel the complexity of plant bio-
chemistry. In addition, one can speculate that the use of 
standardized parts and biobricks for metabolic engineer-
ing of host organisms, via synthetic biology strategies, 
may not be sufficient in all cases, or at least shows that 
much more data are needed for being able to design opti-
mal biosynthetic hosts.
Plants may have evolved multifunctional CYP enzymes 
to lower the metabolic cost of specialized metabolite 
biosynthesis while retaining chemical diversity [37]. The 
interplay of CYP mutants with increased or altered func-
tional properties may result in significant changes in the 
product profiles obtained. Our results show the plastic-
ity of CYP enzymes, which is likely responsible for the 
remarkable diversity of this enzyme superfamily; this 
is reflected not only by the role of these enzymes in the 
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metabolism of all kingdoms of life, but also by the vast 
number of family members that have resulted from gene 
duplications and neofunctionalization.
Methods
Sequences, alignments and SRS determination
Sequences utilized in this work are listed in Additional 
file 1: Table S2 together with primers in Additional file 1: 
Table  S3. SRS regions in CYP76AH15 and CYP76AH8 
were determined by aligning with previously established 
SRS regions in CYP2A1 from Rattus norvegicus (Gen-
bank Accession number: P11711), CYP71D55 from Hyos-
cyamus muticus (Genbank Accession number: A6YIH8) 
and CYP71AJ6 from Thapsia villosa (Genbank Accession 
number: AKJ23347) [14, 17, 18] (Additional file  1: Fig. 
S1).
Homology modeling
Homology modeling to manually inspect the putative 
SRS regions was carried out using UCSF Chimera version 
1.10.2 (University of California) and Modeller 9.15 [38, 
39]. BLAST searches in the PDB database was carried out 
using CYP76AH15 sequence as query to find templates 
(Table 6). Two templates were utilized for modeling using 
default settings in Modeller and inclusion of the HEME 
group from the 3RUK template.
Site‑directed mutagenesis and plasmid construction
Uracil-specific-excision-reagent (USER) cloning [40] was 
utilized for site-directed mutagenesis of CYP76AH15 and 
USER primers were designed using the online AMUSER 
tool [41]. Variants of CYP76AH15 were generated by 
fully amplifying cloning vector pJET1.2 (Thermo Fischer, 
USA) containing CYP76AH15 with USER specific site-
directed mutagenesis primers and purification of PCR 
products using a PCR-purification kit (QIAquick PCR 
Purification Kit, Qiagen, USA), enzymatic treatment with 
DnpI (New England Biolabs, USA) and performing USER 
cloning and Escherichia coli transformation as previously 
described [41]. Plasmids were recovered using mini-
prep kits (Qiaprep Spin Miniprep Kit, Qiagen, USA). 
CYP76AH15 variants from pJET1.2 were USER cloned 
into yeast single integration vectors and assembler vec-
tors as previously described [9].
Saccharomyces cerevisiae strain construction, growth 
and extraction of metabolites
Yeast strain EFCS4498 [5] was utilized as the par-
ent strain for all generated yeast strains regarding 
13R-manoyl oxide production and forskolin production 
(Table  3). All constructs were genomically integrated at 
the XI-5 or X-3 site [42]. Yeast strains producing miltira-
diene were constructed as previously described [9] using 
the yeast assembler system and the XI-2 site [42] and 
strain S288C.
Yeast strains were transformed according to the lith-
ium-acetate protocol [43]. Plasmids were digested with 
NotI (New England Biolabs, USA) to release integration 
cassettes and the digest mixes were added to the yeast 
transformation reactions without purification. Trans-
formed yeast cells were selected on synthetic complete 
plates lacking uracil (SC-URA) prepared from drop-out 
powder (Sigma-Aldrich, Germany) and genotypes were 
confirmed by PCR.
Production of diterpenes in engineered S. cerevisiae 
was carried out as previously described in microtiter 
plate formats using feed-in-time (FIT) medium (m2p 
Labs, Germany) to mimick Fed-batch conditions [9]. 
Vitamins and enzyme solutions were added to final con-
centrations of 1% (v/v) and 0.8% (v/v), respectively in 
yeast strains producing 13R-manoyl oxide and miltiradi-
ene. Pre-cultures were grown for 16 h (280 RPM at 30 °C) 
in 500  μL selective medium (SC-URA). Next, 50 μL of 
the pre-culture was transferred to 500 μL FIT medium 
in microtiter plates for diterpene production screen-
ing, over 72  h. Shake-flask experiments of CYP76AH15 
mutants alone were carried out by innoculating 5  mL 
pre-cultures in selective medium (SC-URA) for 16  h 
(280 RPM at 30  °C) and transferring 3  mL pre-cultures 
to 25 mL FIT medium in 250 mL Erlenmeyer flasks that 
were left shaking for 72 h (180 RPM at 30 °C). Shake-flask 
experiments of strains producing forskolin were carried 
by inoculating 5  mL pre-cultures in selective medium 
(SC-URA) for 16 h (180 RPM at 30 °C) and transferring 
1  mL pre-cultures to 9  mL FIT medium (0.5% enzyme 
mix added and 4% additional sugar added) in 100 mL baf-
fled shake-flasks shaking for 72 h (180 RPM at 30 °C).
For gas-chromatography-mass-spectrometry (GC–
MS) analysis, 0.4  mL of the yeast cells and broth was 
transferred to 1.5  mL glass vials and 0.4  mL n-hexane 
(GC grade) added, spiked with 1  mg/L 1-eicosene as 
internal standard. Samples were vortexed for 5  s and 
left shaking (> 200 RPM, room temperature, 1  h). Next, 
200–300 μL of the hexane phase were transferred to new 
1.5 mL glass vials with inserts ready for GC–MS analysis.
For liquid-chromatography-mass-spectrometry 
(LC–MS) analysis, 0.1  mL of the yeast cells and broth 
was transferred to 1.5  mL glass vials and added 0.4  mL 
Table 6 Templates used for  homology modeling 
of CYP76AH15
Target Templates Sequence 
identity (%)
PDB number
CYP76AH15 CYP17A 29 3RUK_A
CYP2A13 26 4EJI_A
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acetonitrile (HPLC grade). Samples were vortexed 5 s and 
left shaking (> 200 RPM, room temperature, 1  h). Next, 
200–300 μL were filtered and transferred to new 1.5 mL 
glass vials with inserts ready for LC–MS analysis.
GC–MS analysis of diterpenes
A Shimadzu GCMS-QP2010 Ultra system fitted with an 
Agilent HP-5MS column (30 m × 0.25 mm i.d., 0.25 µm 
film thickness) was utilized for GC–MS analysis. Injec-
tion volume was set to 1 µL and the injection tem-
perature at 250  °C with the following GC program for 
13R-manoyl oxide related samples: 60 °C for 1 min, ramp 
at rate 30  °C/min to 180  °C, ramp at rate 10  °C/min to 
280 °C and hold for 3 min. The total run time was 18 min. 
The temperature program for miltiradiene related sam-
ples was: 80  °C for 2  min, ramp at rate 30  °C/min to 
170 °C and hold 3 min, ramp at rate 30 °C/min to 280 °C 
and hold for 3 min. The total run time was 14.67 min.
The ion source temperature of the mass spectrometer 
(MS) was set to 250 °C and spectra were recorded from 
50 to m/z 350 (13R-manoyl oxide samples) and 50 to 
400 m/z (miltiradiene samples). Compound identification 
was carried out using authentic standards and compari-
son to reference spectra in databases (Wiley Registry of 
Mass Spectral Data, 8th Edition, July 2006, John Wiley & 
Sons, ISBN: 978-0-470-04785-9) and previously reported 
spectra [4, 9]. Relative differences in diterpene yields 
were based on an average of the total ion chromatogram 
(TIC) peak area for the compound of interest normalized 
to the TIC area of the internal standard (IS). Compounds 
analyzed by GC–MS in this work were 13R-manoyl oxide 
(1), 11-oxo-13R-manoyl oxide (2), 11β-hydroxy-13R-
manoyl oxide (3), miltiradiene (4), abietatriene (5), fer-
ruginol (6), an unidentified oxo-hydroxy-13R-manoyl 
oxide compound (7) and 9-hydroxy-13R-manoyl oxide 
(8).
Quantification of diterpenes produced by Saccharomyces 
cerevisiae by GC–MS
13R-manoyl oxide was obtained as previously described 
[44]. A standard of 11-oxo-13R manoyl oxide was isolated 
from 100 mL S. cerevisiae culture expressing SpGGPPS7, 
CfTPS2, CfTPS3, the A99I variant of CYP76AH15 and 
CfPOR, likewise using solid phase extraction (Dual 
Layer Florisil/Na2SO4 6 ml PP SPE Tube, Sigma-Aldrich, 
USA) and eluted using a gradient of n-hexane contain-
ing EtOAc in concentrations of 0.25%, 0.5%, and 1–8%. 
11-oxo-13R-manoyl oxide was obtained as 7  mg white 
powder upon evaporation of the 1–3% EtOAc contain-
ing fractions. The powder was resuspended in hexane 
and standard curves of both 13R-manoyl oxide and 
11-oxo-13R-manoyl oxide were prepared spiked with 
10 mg/L 1-eicosene as an internal standard. An unknown 
oxo-hydroxy-13R-manoyl oxide 7 was quantified assum-
ing an identical response factor to 11-oxo-13R-manoyl 
oxide. Yeast cells and culture medium to be quantified 
for diterpene productions were extracted as previously 
described with n-hexane spiked with 10 mg/L 1-eicosene 
as an internal standard.
LC–MS analysis of forskolin producing yeast strains
The Ultimate 3000 UHPLC + Focused system (Dionex 
Corporation, USA) was utilized as LC component while 
coupled to a Bruker Compact ESI-QTOF-MS (Bruker 
Daltonik, Germany) to analyze forskolin containing 
samples. Separation of samples was carried out using a 
Kinetex XB-C18 column (100 × 2.1 mm i.d., 1.7 μm par-
ticle size, 100 Å pore size; Phenomenex Inc., USA) main-
tained at 40 °C. The flow rate was set to 0.3 mL/min with 
a mobile phase consisting of 0.05% (v/v) formic acid in 
water (solvent A) and 0.05% (v/v) formic acid in acetoni-
trile (solvent B). A gradient LC method was used with 
solvent B at 20% for 30  s, ramped to 100% for 8.5  min, 
hold at 100% for 2 min and lowered to 20% over 30 s and 
final hold for 3.5  min. Total run time was 15  min. The 
ESI source parameters were as follows: capillary volt-
age, 4500  V, nebulizer pressure 1.2  bar; dry gas flow, 
8 L/min and the dry gas temperature set to 250  °C. MS 
mode only was set on the qTOF-MS and the collision cell 
energy at 7 eV. Collision cell RF was set to 500 Vpp and 
ions were monitored in the positive mode over a range of 
50–1300 m/z and spectra collected at a rate of 2 Hz.
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